These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11430457)

  • 1. Benefit of IL-2 therapy in HIV patients confirmed.
    Abrams D
    Am Fam Physician; 2001 Jun; 63(12):2424. PubMed ID: 11430457
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of interleukin-2 in human immunodeficiency virus infection.
    Anaya JP; Sias JJ
    Pharmacotherapy; 2005 Jan; 25(1):86-95. PubMed ID: 15767224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 study web site available.
    AIDS Patient Care STDS; 2001 Apr; 15(4):230. PubMed ID: 11370652
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2 for the management of HIV infection.
    Romanelli F
    J Am Pharm Assoc (Wash); 1999; 39(6):867-8. PubMed ID: 10609454
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin-2 in clinical trials: other factors to be considered.
    Nannini EC
    J Infect Dis; 2001 Feb; 183(4):679-80. PubMed ID: 11170999
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical value of adjunctive interleukin-2: clarifications and corrections.
    Hengge UR
    J Infect Dis; 2003 Jan; 187(2):340; author reply 340-1. PubMed ID: 12552465
    [No Abstract]   [Full Text] [Related]  

  • 7. IL-2 therapy provides no clinical benefit to HIV-infected patients on ART.
    Clin Infect Dis; 2009 Apr; 48(8):iii. PubMed ID: 19301459
    [No Abstract]   [Full Text] [Related]  

  • 8. "Lunch and learn" with Dr. Melanie Thompson sheds light on IL2.
    Wilder TL
    Surviv News (Atlanta Ga); 2001 Aug; ():12-3. PubMed ID: 11682743
    [No Abstract]   [Full Text] [Related]  

  • 9. The potential role of interleukin-2 in patients with HIV infection.
    Paredes R; López Benaldo de Quirós JC; Fernández-Cruz E; Clotet B; Lane HC
    AIDS Rev; 2002; 4(1):36-40. PubMed ID: 11998783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
    Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
    Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients.
    Herzmann C; Cuthbertson Z; Fosdick L; Fisher M; Nelson M; Perry N; Law M; Wand H; Janossy G; Johnson MA; Youle M
    J Antimicrob Chemother; 2008 Sep; 62(3):583-6. PubMed ID: 18587135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
    Mitsuyasu R; Gelman R; Cherng DW; Landay A; Fahey J; Reichman R; Erice A; Bucy RP; Kilby JM; Lederman MM; Hamilton CD; Lertora J; White BL; Tebas P; Duliege AM; Pollard RB;
    Arch Intern Med; 2007 Mar; 167(6):597-605. PubMed ID: 17389292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.
    Marchetti G; Meroni L; Varchetta S; Terzieva V; Bandera A; Manganaro D; Molteni C; Trabattoni D; Fossati S; Clerici M; Galli M; Moroni M; Franzetti F; Gori A
    J Infect Dis; 2002 Sep; 186(5):606-16. PubMed ID: 12195347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus.
    Tavel JA; Sereti I; Walker RE; Hahn B; Kovacs JA; Jagannatha S; Davey RT; Falloon J; Polis MA; Masur H; Metcalf JA; Stevens R; Rupert A; Baseler M; Lane HC
    J Infect Dis; 2003 Aug; 188(4):531-6. PubMed ID: 12898439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
    Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP;
    J Infect Dis; 2009 Jul; 200(2):206-15. PubMed ID: 19508157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2: from T cell growth and homeostasis to immune reconstitution of HIV patients.
    Kryworuchko M; Thèze J
    Vitam Horm; 2006; 74():531-47. PubMed ID: 17027529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial immune reconstitution following highly active antiretroviral therapy: can adjuvant interleukin-2 fill the gap?
    Marchetti G; Franzetti F; Gori A
    J Antimicrob Chemother; 2005 Apr; 55(4):401-9. PubMed ID: 15731201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2: trials and tribulations.
    Kuritzkes DR
    J Infect Dis; 2009 Jul; 200(2):164-5. PubMed ID: 19508158
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.
    Tedaldi EM; Chen L; Markowitz N; Kelly L; Abrams D;
    J Viral Hepat; 2005 Jul; 12(4):414-20. PubMed ID: 15985013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients.
    Marchetti G; Meroni L; Molteni C; Taskaris G; Gazzola L; Galli M; Clerici M; Moroni M; Franzetti F; Gori A
    Antivir Ther; 2004 Jun; 9(3):447-52. PubMed ID: 15259908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.